Malaysia-based healthtech startup Naluri Hidup raised approximately RM1 million (US$250,000) in seed funding from Singapore-based healthcare analytics company BioMark and 500 Startups’ Southeast Asia-focussed fund 500 Durians.
The funding will be used to complete product development as well as commercial and clinical trials with the startup’s industry partners.
“Our goal is for clinical trials to be completed this year, to enable the follow-up funding based on the results of the trials.
“Our platform will start as primarily a B2B platform for our partners (insurance companies, corporate employers, and hospitals) and we are expecting to launch our first trial with the platform by the first quarter of this year,” Naluri co-founder Azran Osman-Rani told e27 in an email.
Co-founded in mid-2017 by Osman-Rani, Dr. Jeremy Ting and Dr. Hariyati Abdul Majid, Naluri is a platform that connect users with dedicated health psychologists.
They provide personalised coaching and use evidence-based Cognitive Behavioural Therapy and Motivational Interviewing techniques to strengthen users’ mental resilience and resolve.
The aim is to achieve and sustain better health outcomes such as weight loss, better stress management, or reduction in blood pressure or blood sugar levels.